Organogenesis Ownership | Who Owns Organogenesis?


OverviewForecastRevenueFinancialsChartTranscripts

Organogenesis Ownership Summary


Organogenesis is owned by 45.50% institutional investors, 46.69% insiders, and 7.80% retail investors. Morgan stanley is the largest institutional shareholder, holding 9.17% of ORGO shares. Xtrackers S&P 500 Swap ETF 1C is the top mutual fund, with 2.54% of its assets in Organogenesis shares.

ORGO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOrganogenesis45.50%46.69%7.80%
SectorHealthcare Stocks 232.01%10.74%-142.75%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.82%11.62%67.56%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley11.64M9.17%$60.29M
Soleus capital management9.99M7.87%$51.73M
First light asset management7.50M5.91%$31.64M
Assenagon asset management5.54M4.36%$28.67M
Vanguard group4.96M3.91%$25.69M
Blackrock5.09M3.86%$14.24M
Blackrock funding, inc. /de4.76M3.75%$24.66M
Deutsche bank ag\3.30M2.60%$17.08M
Dimensional fund advisors lp2.73M2.15%$14.15M
Geode capital management1.79M1.41%$9.26M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
First light asset management7.50M2.98%$31.64M
Soleus capital management9.99M1.91%$51.73M
Highmark wealth management303.03K0.64%$1.57M
Wealth dimensions group407.96K0.35%$1.72M
Intrepid family office80.10K0.28%$338.02K
Caitong asset management17.63K0.25%$91.33K
Kent lake capital151.91K0.19%$425.33K
Ajovista15.51K0.13%$43.44K
Pharvision advisers36.70K0.09%$154.88K
Gsa capital partners llp191.47K0.09%$992.00K

Top Buyers

HolderShares% AssetsChange
Norges bank1.10M0.00%1.10M
Jane street group881.69K0.00%793.84K
First light asset management7.50M2.98%720.75K
Assenagon asset management5.54M0.04%680.39K
Sg americas securities565.50K0.00%376.62K

Top Sellers

HolderShares% AssetsChange
Soleus capital management9.99M1.91%-2.15M
Driehaus capital management---1.80M
Aqr capital management1.52M0.01%-1.19M
Healthcare of ontario pension plan trust fund---649.90K
Lazard asset management---649.38K

New Positions

HolderShares% AssetsChangeValue
Norges bank1.10M0.00%1.10M$5.69M
Hrt financial lp274.81K0.00%274.81K$1.42M
Kent lake capital151.91K0.19%151.91K$425.33K
Pharvision advisers36.70K0.09%36.70K$154.88K
Axq capital, lp36.56K0.04%36.56K$189.39K

Sold Out

HolderChange
Assetmark-4.00
Northwestern mutual wealth management-10.00
Nelson, van denburg & campbell wealth management group-13.00
Clearstead advisors-13.00
Us bancorp \de\-33.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025107-11.57%57,735,956-15.59%451.56%48-9.43%38-17.39%
Sep 30, 2025114-68,359,384-1.48%531.80%48-5.88%44-6.38%
Jun 30, 2025113-17.52%69,296,6277.39%542.09%50-32.43%472.17%
Mar 31, 202513613.33%64,503,6783.15%512.30%7417.46%4631.43%
Dec 31, 202443-61.61%19,203,473-69.76%140.63%19-64.15%11-71.79%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Xtrackers S&P 500 Swap ETF 1C3.22M2.54%-23.78K
Xtrackers S&P 500 2xLev Dly Swap ETF 1C2.41M1.82%-
Xtrackers S&P Global Infra Swap ETF 1C2.08M1.64%-
Vanguard Total Stock Mkt Idx Inv1.99M1.57%-
iShares Russell 2000 ETF1.66M1.31%104.96K
Vanguard US Total Market Shares ETF1.59M1.25%-
Invesco Consumer Discr S&P US SelSec ETF1.54M1.21%1.54M
Vanguard Institutional Extnd Mkt Idx Tr804.68K0.63%1.34K
Heptagon Driehaus US Micro Cap Eq C$ Acc703.51K0.55%-9.64K
Fidelity Small Cap Index692.36K0.55%5.73K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 09, 2026Leibowitz Arthur S-Buy$13.40K
Mar 09, 2026Driscoll Michael Joseph-Buy$26.69K
Dec 16, 2025NUSSDORF GLENN H-Sell$1.03M
Nov 25, 2025NUSSDORF GLENN H Sell$63.83K
Nov 24, 2025NUSSDORF GLENN H Sell$534.00K

Insider Transactions Trends


DateBuySell
2026 Q11-
2025 Q4-4
2025 Q3--
2025 Q23-
2025 Q1-1

ORGO Ownership FAQ


Who Owns Organogenesis?

Organogenesis shareholders are primarily institutional investors at 45.50%, followed by 46.69% insiders and 7.81% retail investors. The average institutional ownership in Organogenesis's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.82%, which Organogenesis exceeds.

Who owns the most shares of Organogenesis?

Organogenesis’s largest shareholders are Morgan stanley (11.64M shares, 9.17%), Soleus capital management (9.99M shares, 7.87%), and First light asset management (7.5M shares, 5.91%). Together, they hold 22.95% of Organogenesis’s total shares outstanding.

Does Blackrock own Organogenesis?

Yes, BlackRock owns 3.86% of Organogenesis, totaling 5.09M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 14.24M$. In the last quarter, BlackRock increased its holdings by 112.84K shares, a 2.27% change.

Who is Organogenesis’s biggest shareholder by percentage of total assets invested?

First light asset management is Organogenesis’s biggest shareholder by percentage of total assets invested, with 2.98% of its assets in 7.5M Organogenesis shares, valued at 31.64M$.

Who is the top mutual fund holder of Organogenesis shares?

Xtrackers S&P 500 Swap ETF 1C is the top mutual fund holder of Organogenesis shares, with 2.54% of its total shares outstanding invested in 3.22M Organogenesis shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools